Latest On Allogene Therapeutics, Inc (ALLO):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-04 09:00 EST | News | Allogene Therapeutics, Inc. (ALLO) Q1 2023 Earnings Call Transcript | N/A |  |
| 2023-05-04 09:00 EST | News | Allogene Therapeutics, Inc. 2023 Q1 - Results - Earnings Call Presentation | N/A | |
| 2023-05-03 20:46 EST | News | Allogene Therapeutics GAAP EPS of -$0.68 misses by $0.06, revenue of $0.05M beats by $0.04M | N/A | |
| 2023-05-02 19:29 EST | News | Allogene Therapeutics Q1 2023 Earnings Preview | N/A | |
| 2023-03-03 18:05 EST | News | Allogene: ALLO-715 Phase 1 Results And ALLO-213 Preclinical Data Is Promising | N/A | |
| 2023-03-01 07:09 EST | News | Allogene Therapeutics GAAP EPS of -$0.66 beats by $0.04, revenue of $0.05M misses by $0.01M | N/A | |
| 2023-03-01 07:09 EST | News | Allogene Therapeutics, Inc. (ALLO) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-02-28 01:16 EST | News | Allogene Therapeutics Q4 2022 Earnings Preview | N/A | |
| 2023-01-24 12:15 EST | News | Allogene stock rises ~15% as JPMorgan upgrades on near-term catalysts | N/A | |
| 2023-01-06 22:18 EST | News | Allogene Therapeutics up 7% following upgrade from Baird | N/A | |
| 2023-01-03 12:33 EST | News | Allogene ends winning streak as R&D chief departs | N/A | |
| 2022-12-13 02:21 EST | News | Allogene down 11% following downgrade to underperform at BofA | N/A | |
| 2022-12-02 18:35 EST | News | Allogene: Pioneering Allogeneic CAR-T Developer With No Near-Term Catalysts | N/A | |
| 2022-11-17 00:51 EST | News | Allogene Therapeutics (ALLO) Investor presntation - Slideshow | N/A | |
| 2022-11-03 05:19 EST | News | Allogene Therapeutics GAAP EPS of -$0.58 beats by $0.06, revenue of $0.05M beats by $0.04M | N/A | |
| 2022-11-03 05:19 EST | News | Allogene Therapeutics, Inc. (ALLO) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-01 22:08 EST | News | Allogene Therapeutics Q3 2022 Earnings Preview | N/A | |
| 2022-10-06 22:48 EST | News | Allogene begins phase 2 allogeneic CAR T trial for large B-cell lymphoma candidate | N/A | |
| 2022-09-21 21:21 EST | News | Allogene slips as Servier exits partnership for CD19 products | N/A | |
| 2022-09-14 00:36 EST | News | Allogene: Possible First Pivotal Study With Allogeneic CAR-T ALLO-501A | N/A | |
| 2022-08-16 04:03 EST | News | Allogene Therapeutics, Inc. 2022 Q2 - Results - Earnings Call Presentation | N/A | |
| 2022-08-11 05:48 EST | News | Allogene stock rises on Q2 beat despite downgrade at Raymond James; eyes FDA nod for ALLO-501A trial in 'coming weeks' | N/A | |
| 2022-08-10 12:06 EST | News | Allogene Therapeutics, Inc.'s (ALLO) CEO David Chang on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-10 12:05 EST | News | Allogene downgraded to market perform from outperform at Raymond James | N/A | |
| 2022-08-09 18:14 EST | News | Allogene Therapeutics GAAP EPS of -$0.52 beats by $0.08, revenue of $0.09M beats by $0.07M | N/A | |
| 2022-08-08 18:26 EST | News | Allogene Therapeutics Q2 2022 Earnings Preview | N/A | |
| 2022-07-15 09:02 EST | News | Allogene stock rises as Goldman ups rating to Buy on way forward for cancer programs | N/A | |
| 2022-06-24 21:23 EST | News | Allogene Therapeutics: Multibagger Potential, But Terribly Risky | N/A | |
| 2022-06-08 15:04 EST | News | Allogene's ALLO-501A for lymphoma gets regenerative medicine advanced therapy designation | N/A | |
| 2022-05-05 20:58 EST | News | Allogene Therapeutics, Inc. (ALLO) CEO David Chang on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-04 22:11 EST | News | Allogene Therapeutics GAAP EPS of -$0.56 beats by $0.02 | N/A | |
| 2022-05-04 03:01 EST | News | Allogene Therapeutics Q1 2022 Earnings Preview | N/A | |
| 2022-04-27 18:19 EST | News | Allogene multiple myeloma candidate granted Orphan Drug Designation | N/A | |
| 2022-04-14 19:02 EST | News | Allogene Therapeutics opens new manufacturing site in California | N/A | |
| 2022-04-02 12:50 EST | News | Allogene: Speculative CAR T Biotech With Big Potential In Oncology | N/A | |
| 2022-04-01 18:50 EST | News | Allogene: Leading The Allogeneic CAR-T Space, Again | N/A | |
| 2022-02-24 08:21 EST | News | Allogene Therapeutics GAAP EPS of -$0.54 beats by $0.06, revenue of $51M | N/A | |
| 2022-02-24 08:21 EST | News | Allogene Therapeutics, Inc. (ALLO) CEO David Chang on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-02-24 08:21 EST | News | Allogene Therapeutics, Inc. 2021 Q4 - Results - Earnings Call Presentation | N/A | |
| 2022-02-22 17:43 EST | News | Allogene Therapeutics Q4 2021 Earnings Preview | N/A | |
| 2022-01-28 20:09 EST | News | Allogene Therapeutics (ALLO) Investor Presentation (Slideshow) | N/A | |
| 2022-01-12 18:10 EST | News | Allogene: Lifting Of The Clinical Hold Will Be A Major Binary | N/A | |
| 2022-01-12 00:38 EST | News | Allogene to work with Antion on miRNA technology for multiplex gene silencing | N/A | |
| 2022-01-11 07:54 EST | News | Allogene closes down 9% despite lifting of clinical hold; other gene editing names mixed | N/A | |
| 2022-01-10 15:23 EST | News | FDA removes clinical hold on Allogene's all AlloCAR T clinical trials | N/A | |
| 2021-12-15 05:33 EST | News | Allogene Therapeutics (ALLO) Presents At 63rd Annual Meeting of ASH - Slideshow | N/A | |
| 2021-11-12 16:26 EST | News | Warning: ALLO is at high risk of performing badly | N/A | |
| 2021-11-05 00:41 EST | News | Allogene Therapeutics EPS misses by $0.01 | N/A | |
| 2021-11-05 00:41 EST | News | Allogene Therapeutics' (ALLO) CEO David Chang on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-10-20 02:12 EST | News | Ramifications Of Allogene's Clinical Hold: Possible Sector-Wide Implications | N/A | |
About Allogene Therapeutics, Inc (ALLO):
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult patients with R/R CD19 positive B-cell ALL. The company also develops ALLO-501, an anti-CD19 allogeneic CAR T cell product candidate that is in Phase I clinical trial for the treatment of R/R non-Hodgkin lymphoma; and ALLO-501A, which is in Phase I/II clinical trial for the treatment R/R large B-cell lymphoma or transformed follicular lymphoma. In addition, it is developing ALLO-715, an allogeneic CAR T cell product candidate that is in a Phase I clinical trial for treating R/R multiple myeloma; ALLO-819, an allogeneic CAR T cell product candidates for the treatment of acute myeloid leukemia; ALLO-605, an allogeneic CAR T cell product candidate for the treatment of multiple myeloma; ALLO-647, an anti-CD52 monoclonal antibody; CD70 to treat renal cell cancer; and DLL3 for the treatment of small cell lung cancer and other aggressive neuroendocrine tumors. The company has license and collaboration agreements with Pfizer Inc.; Servier; Cellectis S.A.; and Notch Therapeutics Inc., as well as clinical trial collaboration agreement with SpringWorks Therapeutics, Inc. It also has a strategic collaboration agreement with The University of Texas MD Anderson Cancer Center for the preclinical and clinical investigation of allogeneic CAR T cell product candidates. The company was founded in 2017 and is headquartered in South San Francisco, California.
General
- Name Allogene Therapeutics, Inc
- Symbol ALLO
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 264
- Fiscal Year EndDecember
- IPO Date2018-10-11
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.allogene.com
View More
Valuation
- Price/Book (Most Recent Quarter) 4.86
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$2.19
- Next Year EPS Estimate -$2.61
- Next Quarter EPS Estimate -$0.56
- Return on Assets -17%
- Return on Equity -29%
- Earnings Per Share -$2.07
- Revenue Per Share $0
- Quarterly Earnings Growth 0%
View More
Highlights
- Market Capitalization 5.14 billion
- EBITDA -134911008
- PE Ratio -1.74
- Analyst Target Price $50.62
- Book Value Per Share $7.69
View More
Share Statistics
- Shares Outstanding 140.65 million
- Shares Float 73.67 million
- % Held by Insiders 3574%
- % Held by Institutions 61.5%
- Shares Short 11.55 million
- Shares Short Prior Month 11.08 million
- Short Ratio 14.39
- Short % of Float 14%
- Short % of Shares Outstanding 8%
View More
Technicals
- Beta 1.16
- 52 Week High $55
- 52 Week Low $17.79
- 50 Day Moving Average 35.26
- 200 Day Moving Average 33.35
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Allogene Therapeutics, Inc (ALLO) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Allogene Therapeutics, Inc (ALLO) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-25 | $N/A | -$0.53 | -$0.55 | 3.64% |
| 2020-09-30 | 2020-11-04 | $N/A | -$0.52 | -$0.55 | 6.12% |
| 2020-06-30 | 2020-08-05 | $N/A | -$0.53 | -$0.54 | 2.23% |
| 2020-03-31 | 2020-05-06 | $N/A | -$0.50 | -$0.58 | 13.57% |
| 2019-12-31 | 2020-02-27 | $N/A | -$0.58 | -$0.68 | 14.59% |
| 2019-09-30 | 2019-11-05 | $N/A | -$0.50 | -$0.54 | 7.92% |
| 2019-06-30 | 2019-08-07 | $N/A | -$0.41 | -$0.44 | 7.53% |
| 2019-03-31 | 2019-05-07 | $N/A | -$0.32 | -$0.44 | 26.66% |
| 2018-12-31 | 2019-03-08 | $N/A | -$0.37 | -$0.25 | -45.67% |
| 2018-09-30 | 2018-11-21 | $N/A | -$0.43 | -$0.39 | -11.31% |
Allogene Therapeutics, Inc (ALLO) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Allogene Therapeutics, Inc (ALLO) Chart:
Allogene Therapeutics, Inc (ALLO) News:
Below you will find a list of latest news for Allogene Therapeutics, Inc (ALLO) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Allogene Therapeutics, Inc (ALLO) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2024-05-17 | 2.5 | 0.65 | CALL | 11 | 1126 | 111.29 | TRUE | 0.65 | 0 |
| 2024-05-17 | 5 | 0.05 | CALL | 0 | 861 | 160 | FALSE | 0 | 0 |
| 2024-05-17 | 7.5 | 0.05 | CALL | 10 | 1199 | 220.18 | FALSE | 0.05 | 0 |
| 2024-05-17 | 10 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 2.5 | 0.09 | PUT | 0 | 391 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 5 | 1.52 | PUT | 0 | 44 | 144.41 | TRUE | 0 | 0 |
| 2024-05-17 | 7.5 | 0 | PUT | 0 | 0 | 312.86 | TRUE | 0 | 0 |
| 2024-05-17 | 10 | 0 | PUT | 0 | 0 | 394.65 | TRUE | 0 | 0 |
| 2024-06-21 | 2.5 | 0 | CALL | 0 | 0 | 88.15 | TRUE | 0 | 0 |
| 2024-06-21 | 5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 7.5 | 0.05 | CALL | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 2.5 | 0.15 | PUT | 0 | 5 | 97.89 | FALSE | 0 | 0 |
| 2024-06-21 | 5 | 1.7 | PUT | 0 | 2 | 105.15 | TRUE | 0 | 0 |
| 2024-06-21 | 7.5 | 0 | PUT | 0 | 0 | 283.92 | TRUE | 0 | 0 |
| 2024-08-16 | 2.5 | 1.35 | CALL | 0 | 111 | 102.71 | TRUE | 0 | 0 |
| 2024-08-16 | 5 | 0.25 | CALL | 0 | 2066 | 99.95 | FALSE | 0 | 0 |
| 2024-08-16 | 7.5 | 0.1 | CALL | 3 | 99 | 112.12 | FALSE | 0.1 | 0 |
| 2024-08-16 | 10 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 2.5 | 0.37 | PUT | 5 | 163 | 102.55 | FALSE | 0.37 | 0 |
| 2024-08-16 | 5 | 1.2 | PUT | 0 | 11 | 90.34 | TRUE | 0 | 0 |
| 2024-08-16 | 7.5 | 0 | PUT | 0 | 0 | 183.72 | TRUE | 0 | 0 |
| 2024-08-16 | 10 | 0 | PUT | 0 | 0 | 237.74 | TRUE | 0 | 0 |
| 2024-11-15 | 2.5 | 1.04 | CALL | 20 | 2 | 86.48 | TRUE | 1.04 | 0 |
| 2024-11-15 | 5 | 0.35 | CALL | 4 | 6 | 88.72 | FALSE | -0.15 | -0.3 |
| 2024-11-15 | 7.5 | 0.4 | CALL | 0 | 19 | 110.53 | FALSE | 0 | 0 |
| 2024-11-15 | 10 | 0.25 | CALL | 0 | 1 | 105.16 | FALSE | 0 | 0 |
| 2024-11-15 | 2.5 | 0.35 | PUT | 1 | 1 | 75.34 | FALSE | 0.35 | 0 |
| 2024-11-15 | 5 | 1.9 | PUT | 0 | 35 | 91.49 | TRUE | 0 | 0 |
| 2024-11-15 | 7.5 | 0 | PUT | 0 | 0 | 109.96 | TRUE | 0 | 0 |
| 2024-11-15 | 10 | 0 | PUT | 0 | 0 | 124.27 | TRUE | 0 | 0 |
Latest ALLO Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 100 | $8.845 |
| Jun 13, 2022 7:59 PM EST | 5 | $8.845 |
| Jun 13, 2022 7:59 PM EST | 4 | $8.845 |
| Jun 13, 2022 7:59 PM EST | 20 | $8.84 |
| Jun 13, 2022 7:59 PM EST | 47 | $8.85 |
Allogene Therapeutics, Inc (ALLO) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000138713120006093/0001387131-20-006093-index.htm |
| 2018-10-10 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000007800318000079/0000078003-18-000079-index.htm |
| 2018-10-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000007800318000080/0000078003-18-000080-index.htm |
| 2018-10-22 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1737287/000007800318000083/0000078003-18-000083-index.htm |
| 2018-10-10 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000090342318000545/0000903423-18-000545-index.htm |
| 2018-10-10 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000090342318000546/0000903423-18-000546-index.htm |
| 2018-10-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000090342318000561/0000903423-18-000561-index.htm |
| 2018-10-25 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1737287/000090342318000570/0000903423-18-000570-index.htm |
| 2019-02-13 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1737287/000110465919007969/0001104659-19-007969-index.htm |
| 2019-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000114036119009199/0001140361-19-009199-index.htm |
| 2019-05-15 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1737287/000114036119009204/0001140361-19-009204-index.htm |
| 2018-10-11 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/1737287/000119312518297747/0001193125-18-297747-index.htm |
| 2018-10-15 | POS EX | Post-effective amendment adding exhibits to registration statement [Rule 462(d)] | https://www.sec.gov/Archives/edgar/data/1737287/000119312518299225/0001193125-18-299225-index.htm |
| 2018-10-15 | POS462B | Post-effective amendment to registration statement [Rule 462(b)] | https://www.sec.gov/Archives/edgar/data/1737287/000119312518299286/0001193125-18-299286-index.htm |
| 2018-10-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737287/000119312518299356/0001193125-18-299356-index.htm |
| 2018-10-24 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1737287/000119312518306372/0001193125-18-306372-index.htm |
| 2018-10-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737287/000119312518310633/0001193125-18-310633-index.htm |
| 2018-12-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737287/000119312518348919/0001193125-18-348919-index.htm |
| 2019-02-13 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1737287/000119312519038199/0001193125-19-038199-index.htm |
| 2019-02-13 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1737287/000119312519038201/0001193125-19-038201-index.htm |
| 2019-02-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737287/000119312519044774/0001193125-19-044774-index.htm |
| 2019-03-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737287/000119312519068107/0001193125-19-068107-index.htm |
| 2019-03-08 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1737287/000119312519069173/0001193125-19-069173-index.htm |
| 2019-04-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737287/000119312519102909/0001193125-19-102909-index.htm |
| 2019-04-24 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1737287/000119312519115774/0001193125-19-115774-index.htm |
| 2019-04-24 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1737287/000119312519115862/0001193125-19-115862-index.htm |
| 2019-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737287/000119312519139002/0001193125-19-139002-index.htm |
| 2019-06-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737287/000119312519169316/0001193125-19-169316-index.htm |
| 2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1737287/000119312520035541/0001193125-20-035541-index.htm |
| 2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1737287/000119312520035546/0001193125-20-035546-index.htm |
| 2018-10-10 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000120919118054733/0001209191-18-054733-index.htm |
| 2018-10-10 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000120919118054734/0001209191-18-054734-index.htm |
| 2018-10-10 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000120919118054735/0001209191-18-054735-index.htm |
| 2018-10-10 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000120919118054736/0001209191-18-054736-index.htm |
| 2018-10-10 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000120919118054737/0001209191-18-054737-index.htm |
| 2018-10-10 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000120919118054738/0001209191-18-054738-index.htm |
| 2018-10-10 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000120919118054739/0001209191-18-054739-index.htm |
| 2018-10-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000120919118055372/0001209191-18-055372-index.htm |
| 2018-10-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000120919118055374/0001209191-18-055374-index.htm |
| 2018-10-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000120919118055379/0001209191-18-055379-index.htm |
| 2018-10-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000120919118055385/0001209191-18-055385-index.htm |
| 2018-10-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000120919118055388/0001209191-18-055388-index.htm |
| 2018-10-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000120919118055391/0001209191-18-055391-index.htm |
| 2019-02-13 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000120919119009724/0001209191-19-009724-index.htm |
| 2019-03-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000120919119019755/0001209191-19-019755-index.htm |
| 2019-03-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000120919119019758/0001209191-19-019758-index.htm |
| 2019-03-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000120919119019762/0001209191-19-019762-index.htm |
| 2019-03-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000120919119019767/0001209191-19-019767-index.htm |
| 2019-04-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000120919119026675/0001209191-19-026675-index.htm |
| 2019-04-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000120919119026676/0001209191-19-026676-index.htm |
| 2019-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000120919119030076/0001209191-19-030076-index.htm |
| 2019-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000120919119030079/0001209191-19-030079-index.htm |
| 2019-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000120919119034861/0001209191-19-034861-index.htm |
| 2019-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000120919119038862/0001209191-19-038862-index.htm |
| 2019-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000120919119038864/0001209191-19-038864-index.htm |
| 2019-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000120919119038866/0001209191-19-038866-index.htm |
| 2019-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000120919119038868/0001209191-19-038868-index.htm |
| 2019-07-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000120919119039728/0001209191-19-039728-index.htm |
| 2019-07-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000120919119041955/0001209191-19-041955-index.htm |
| 2019-07-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000120919119041957/0001209191-19-041957-index.htm |
| 2019-07-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000120919119042874/0001209191-19-042874-index.htm |
| 2019-07-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000120919119042877/0001209191-19-042877-index.htm |
| 2019-07-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000120919119043755/0001209191-19-043755-index.htm |
| 2019-09-05 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000121465919005667/0001214659-19-005667-index.htm |
| 2019-09-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000121465919005669/0001214659-19-005669-index.htm |
| 2019-09-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000121465919005740/0001214659-19-005740-index.htm |
| 2019-09-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000121465919005741/0001214659-19-005741-index.htm |
| 2019-09-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000121465919005941/0001214659-19-005941-index.htm |
| 2019-09-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000121465919006019/0001214659-19-006019-index.htm |
| 2019-09-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000121465919006021/0001214659-19-006021-index.htm |
| 2019-10-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000121465919006702/0001214659-19-006702-index.htm |
| 2019-10-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000121465919006703/0001214659-19-006703-index.htm |
| 2019-11-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000121465919007333/0001214659-19-007333-index.htm |
| 2019-11-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000121465919007335/0001214659-19-007335-index.htm |
| 2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000121465920001733/0001214659-20-001733-index.htm |
| 2020-03-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000121465920002528/0001214659-20-002528-index.htm |
| 2020-03-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000121465920002530/0001214659-20-002530-index.htm |
| 2020-03-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000121465920002734/0001214659-20-002734-index.htm |
| 2020-03-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000121465920002735/0001214659-20-002735-index.htm |
| 2020-03-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000121465920002736/0001214659-20-002736-index.htm |
| 2020-03-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000121465920002803/0001214659-20-002803-index.htm |
| 2020-03-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000121465920002804/0001214659-20-002804-index.htm |
| 2020-03-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000121465920002805/0001214659-20-002805-index.htm |
| 2020-03-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000121465920002806/0001214659-20-002806-index.htm |
| 2020-03-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000121465920002807/0001214659-20-002807-index.htm |
| 2020-04-22 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000121465920003629/0001214659-20-003629-index.htm |
| 2020-04-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000121465920003819/0001214659-20-003819-index.htm |
| 2020-04-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000121465920003820/0001214659-20-003820-index.htm |
| 2020-06-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000121465920005383/0001214659-20-005383-index.htm |
| 2020-06-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000121465920005493/0001214659-20-005493-index.htm |
| 2020-06-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000121465920005494/0001214659-20-005494-index.htm |
| 2020-06-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000121465920005495/0001214659-20-005495-index.htm |
| 2020-06-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000121465920005496/0001214659-20-005496-index.htm |
| 2020-08-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000121465920006805/0001214659-20-006805-index.htm |
| 2020-08-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000121465920007184/0001214659-20-007184-index.htm |
| 2020-09-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000121465920007671/0001214659-20-007671-index.htm |
| 2020-09-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000121465920008039/0001214659-20-008039-index.htm |
| 2020-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000121465920008375/0001214659-20-008375-index.htm |
| 2020-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000121465920008378/0001214659-20-008378-index.htm |
| 2020-10-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000121465920008504/0001214659-20-008504-index.htm |
| 2020-10-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000121465920008506/0001214659-20-008506-index.htm |
| 2020-10-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000121465920008508/0001214659-20-008508-index.htm |
| 2020-10-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000121465920008532/0001214659-20-008532-index.htm |
| 2020-10-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000121465920008571/0001214659-20-008571-index.htm |
| 2020-10-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000121465920008703/0001214659-20-008703-index.htm |
| 2020-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000138713120005509/0001387131-20-005509-index.htm |
| 2020-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000138713120005745/0001387131-20-005745-index.htm |
| 2020-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000138713120005873/0001387131-20-005873-index.htm |
| 2020-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000138713120005972/0001387131-20-005972-index.htm |
| 2020-06-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000138713120006093/0001387131-20-006093-index.htm |
| 2020-07-10 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1737287/000138713120006309/0001387131-20-006309-index.htm |
| 2020-08-10 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1737287/000138713120007266/0001387131-20-007266-index.htm |
| 2020-08-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737287/000138713120007268/0001387131-20-007268-index.htm |
| 2020-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1737287/000142284820000012/0001422848-20-000012-index.htm |
| 2018-11-21 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1737287/000156459018030022/0001564590-18-030022-index.htm |
| 2019-03-08 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1737287/000156459019006991/0001564590-19-006991-index.htm |
| 2019-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1737287/000156459019016480/0001564590-19-016480-index.htm |
| 2019-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737287/000173728719000005/0001737287-19-000005-index.htm |
| 2019-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1737287/000173728719000008/0001737287-19-000008-index.htm |
| 2019-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737287/000173728719000016/0001737287-19-000016-index.htm |
| 2019-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1737287/000173728719000020/0001737287-19-000020-index.htm |
| 2019-11-05 | S-3ASR | Automatic shelf registration statement of securities of well-known seasoned issuers | https://www.sec.gov/Archives/edgar/data/1737287/000173728719000022/0001737287-19-000022-index.htm |
| 2019-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737287/000173728719000023/0001737287-19-000023-index.htm |
| 2019-12-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737287/000173728719000025/0001737287-19-000025-index.htm |
| 2020-02-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737287/000173728720000010/0001737287-20-000010-index.htm |
| 2020-02-27 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1737287/000173728720000012/0001737287-20-000012-index.htm |
| 2020-02-27 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1737287/000173728720000013/0001737287-20-000013-index.htm |
| 2020-03-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737287/000173728720000017/0001737287-20-000017-index.htm |
| 2020-04-23 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1737287/000173728720000021/0001737287-20-000021-index.htm |
| 2020-04-23 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1737287/000173728720000022/0001737287-20-000022-index.htm |
| 2020-05-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737287/000173728720000024/0001737287-20-000024-index.htm |
| 2020-05-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1737287/000173728720000027/0001737287-20-000027-index.htm |
| 2020-05-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737287/000173728720000029/0001737287-20-000029-index.htm |
| 2020-06-01 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1737287/000173728720000032/0001737287-20-000032-index.htm |
| 2020-06-03 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1737287/000173728720000036/0001737287-20-000036-index.htm |
| 2020-06-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737287/000173728720000039/0001737287-20-000039-index.htm |
| 2020-06-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737287/000173728720000041/0001737287-20-000041-index.htm |
| 2020-08-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737287/000173728720000045/0001737287-20-000045-index.htm |
| 2020-08-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1737287/000173728720000047/0001737287-20-000047-index.htm |
| 2020-10-26 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1737287/000173728720000050/0001737287-20-000050-index.htm |
| 2020-11-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737287/000173728720000055/0001737287-20-000055-index.htm |
| 2020-11-04 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1737287/000173728720000059/0001737287-20-000059-index.htm |
| 2018-10-10 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1737287/999999999518002586/9999999995-18-002586-index.htm |
| 2018-10-11 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1737287/999999999718008531/9999999997-18-008531-index.htm |
Allogene Therapeutics, Inc (ALLO) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Allogene Therapeutics, Inc (ALLO). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 3574%Institutional Ownership: 6150%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-06-05 | Joshua A Kazam | Director | Buy | 9,969.00 | 1,033,305.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465920005494/0001214659-20-005494-index.htm | ||
| 2019-09-03 | Rafael Amado | EVP of R&D and CMO | Buy | 105,162.00 | 105,162.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465919005669/0001214659-19-005669-index.htm | ||
| 2020-10-09 | ALISON MOORE | Chief Technical Officer | Sell | 39,509.00 | 41.00 | 1,619,869.00 | 108,370.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465920008532/0001214659-20-008532-index.htm |
| 2020-10-12 | ALISON MOORE | Chief Technical Officer | Sell | 24,233.00 | 42.00 | 1,017,786.00 | 108,370.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465920008571/0001214659-20-008571-index.htm |
| 2020-10-13 | ALISON MOORE | Chief Technical Officer | Sell | 11,031.00 | 42.00 | 463,302.00 | 108,370.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465920008571/0001214659-20-008571-index.htm |
| 2020-10-07 | Rafael Amado | EVP of R&D and CMO | Sell | 16,538.00 | 39.40 | 651,514.51 | 111,677.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465920008508/0001214659-20-008508-index.htm |
| 2020-10-06 | ALISON MOORE | Chief Technical Officer | Sell | 44,574.00 | 40.00 | 1,782,960.00 | 117,680.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465920008506/0001214659-20-008506-index.htm |
| 2020-10-08 | ALISON MOORE | Chief Technical Officer | Sell | 5,065.00 | 41.00 | 207,665.00 | 117,680.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465920008532/0001214659-20-008532-index.htm |
| 2020-10-13 | ALISON MOORE | Chief Technical Officer | Buy | 11,031.00 | 2.27 | 25,040.37 | 119,401.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465920008571/0001214659-20-008571-index.htm |
| 2020-10-15 | ERIC THOMAS SCHMIDT | Chief Financial Officer | Sell | 100.00 | 43.01 | 4,301.00 | 1,197,595.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465920008703/0001214659-20-008703-index.htm |
| 2020-10-15 | ERIC THOMAS SCHMIDT | Chief Financial Officer | Sell | 2,099.00 | 42.32 | 88,839.55 | 1,197,695.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465920008703/0001214659-20-008703-index.htm |
| 2020-10-15 | ERIC THOMAS SCHMIDT | Chief Financial Officer | Sell | 3,479.00 | 41.33 | 143,799.59 | 1,199,794.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465920008703/0001214659-20-008703-index.htm |
| 2020-10-15 | ERIC THOMAS SCHMIDT | Chief Financial Officer | Sell | 4,218.00 | 40.07 | 169,010.62 | 1,203,273.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465920008703/0001214659-20-008703-index.htm |
| 2020-10-15 | ERIC THOMAS SCHMIDT | Chief Financial Officer | Sell | 5,104.00 | 39.47 | 201,441.61 | 1,207,491.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465920008703/0001214659-20-008703-index.htm |
| 2019-06-06 | Franz B Humer | Director | Buy | 16,377.00 | 121,247.00 | https://www.sec.gov/Archives/edgar/data/1737287/000120919119038864/0001209191-19-038864-index.htm | ||
| 2020-09-21 | ERIC THOMAS SCHMIDT | Chief Financial Officer | Sell | 1,911.00 | 37.04 | 70,783.44 | 1,212,595.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465920008039/0001214659-20-008039-index.htm |
| 2020-09-21 | ERIC THOMAS SCHMIDT | Chief Financial Officer | Sell | 3,200.00 | 35.96 | 115,069.12 | 1,214,506.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465920008039/0001214659-20-008039-index.htm |
| 2020-09-21 | ERIC THOMAS SCHMIDT | Chief Financial Officer | Sell | 9,889.00 | 34.76 | 343,692.20 | 1,217,706.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465920008039/0001214659-20-008039-index.htm |
| 2020-10-08 | ALISON MOORE | Chief Technical Officer | Buy | 5,065.00 | 2.27 | 11,497.55 | 122,745.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465920008532/0001214659-20-008532-index.htm |
| 2020-08-13 | ALISON MOORE | Chief Technical Officer | Buy | 32,451.00 | 2.27 | 73,663.77 | 126,272.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465920007184/0001214659-20-007184-index.htm |
| 2020-10-01 | Rafael Amado | EVP of R&D and CMO | Sell | 9,752.00 | 36.37 | 354,661.71 | 128,215.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465920008375/0001214659-20-008375-index.htm |
| 2020-06-05 | Franz B Humer | Director | Buy | 9,969.00 | 131,216.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465920005495/0001214659-20-005495-index.htm | ||
| 2020-10-12 | ALISON MOORE | Chief Technical Officer | Buy | 24,233.00 | 2.27 | 55,008.91 | 132,603.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465920008571/0001214659-20-008571-index.htm |
| 2020-03-18 | Rafael Amado | EVP of R&D and CMO | Buy | 30,800.00 | 135,962.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465920002804/0001214659-20-002804-index.htm | ||
| 2019-06-06 | Joshua A Kazam | Director | Buy | 16,377.00 | 1,407,028.00 | https://www.sec.gov/Archives/edgar/data/1737287/000120919119038866/0001209191-19-038866-index.htm | ||
| 2020-10-09 | ALISON MOORE | Chief Technical Officer | Buy | 30,199.00 | 2.27 | 68,551.73 | 147,879.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465920008532/0001214659-20-008532-index.htm |
| 2019-03-13 | Arie Belldegrun | Director | Buy | 115,333.00 | 150,333.00 | https://www.sec.gov/Archives/edgar/data/1737287/000120919119019758/0001209191-19-019758-index.htm | ||
| 2020-10-06 | ALISON MOORE | Chief Technical Officer | Buy | 35,264.00 | 2.27 | 80,049.28 | 161,536.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465920008506/0001214659-20-008506-index.htm |
| 2020-06-04 | Arie Belldegrun | Director | Buy | 106,382.00 | 47.00 | 4,999,954.00 | 1,798,163.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465920005383/0001214659-20-005383-index.htm |
| 2020-08-07 | TPG Group Holdings (SBS) Advisors, Inc. | 10% Share Holder | Sell | 7,686.00 | 37.70 | 289,730.69 | 18,716,306.00 | https://www.sec.gov/Archives/edgar/data/1737287/000138713120007268/0001387131-20-007268-index.htm |
| 2020-08-07 | TPG Group Holdings (SBS) Advisors, Inc. | 10% Share Holder | Sell | 5,605.00 | 37.02 | 207,505.51 | 18,723,992.00 | https://www.sec.gov/Archives/edgar/data/1737287/000138713120007268/0001387131-20-007268-index.htm |
| 2020-08-06 | TPG Group Holdings (SBS) Advisors, Inc. | 10% Share Holder | Sell | 19,554.00 | 37.33 | 730,001.66 | 18,729,597.00 | https://www.sec.gov/Archives/edgar/data/1737287/000138713120007268/0001387131-20-007268-index.htm |
| 2020-08-06 | TPG Group Holdings (SBS) Advisors, Inc. | 10% Share Holder | Sell | 4,600.00 | 38.22 | 175,792.68 | 18,749,151.00 | https://www.sec.gov/Archives/edgar/data/1737287/000138713120007268/0001387131-20-007268-index.htm |
| 2020-06-30 | TPG Group Holdings (SBS) Advisors, Inc. | 10% Share Holder | Sell | 59,747.00 | 42.21 | 2,522,052.31 | 19,716,306.00 | https://www.sec.gov/Archives/edgar/data/1737287/000138713120006093/0001387131-20-006093-index.htm |
| 2020-06-29 | TPG Group Holdings (SBS) Advisors, Inc. | 10% Share Holder | Sell | 24,904.00 | 43.27 | 1,077,543.78 | 19,776,053.00 | https://www.sec.gov/Archives/edgar/data/1737287/000138713120006093/0001387131-20-006093-index.htm |
| 2020-06-26 | TPG Group Holdings (SBS) Advisors, Inc. | 10% Share Holder | Sell | 500.00 | 44.01 | 22,005.00 | 19,800,957.00 | https://www.sec.gov/Archives/edgar/data/1737287/000138713120006093/0001387131-20-006093-index.htm |
| 2020-06-25 | TPG Group Holdings (SBS) Advisors, Inc. | 10% Share Holder | Sell | 72,359.00 | 44.19 | 3,197,327.13 | 19,801,457.00 | https://www.sec.gov/Archives/edgar/data/1737287/000138713120005972/0001387131-20-005972-index.htm |
| 2020-06-24 | TPG Group Holdings (SBS) Advisors, Inc. | 10% Share Holder | Sell | 15,269.00 | 43.93 | 670,713.73 | 19,873,816.00 | https://www.sec.gov/Archives/edgar/data/1737287/000138713120005972/0001387131-20-005972-index.htm |
| 2018-10-15 | OWEN N. WITTE | Director | Buy | 15,000.00 | 18.00 | 270,000.00 | 198,750.00 | https://www.sec.gov/Archives/edgar/data/1737287/000120919118055388/0001209191-18-055388-index.htm |
| 2020-06-23 | TPG Group Holdings (SBS) Advisors, Inc. | 10% Share Holder | Sell | 22,213.00 | 44.31 | 984,235.82 | 19,889,085.00 | https://www.sec.gov/Archives/edgar/data/1737287/000138713120005972/0001387131-20-005972-index.htm |
| 2020-06-23 | TPG Group Holdings (SBS) Advisors, Inc. | 10% Share Holder | Sell | 110,012.00 | 43.91 | 4,830,373.89 | 19,911,298.00 | https://www.sec.gov/Archives/edgar/data/1737287/000138713120005972/0001387131-20-005972-index.htm |
| 2018-10-15 | David D Chang | President and CEO | Buy | 40,000.00 | 18.00 | 720,000.00 | 1,995,625.00 | https://www.sec.gov/Archives/edgar/data/1737287/000120919118055374/0001209191-18-055374-index.htm |
| 2020-06-22 | TPG Group Holdings (SBS) Advisors, Inc. | 10% Share Holder | Sell | 42,855.00 | 43.16 | 1,849,827.50 | 20,021,310.00 | https://www.sec.gov/Archives/edgar/data/1737287/000138713120005873/0001387131-20-005873-index.htm |
| 2020-06-22 | TPG Group Holdings (SBS) Advisors, Inc. | 10% Share Holder | Sell | 129,570.00 | 42.72 | 5,534,893.52 | 20,064,165.00 | https://www.sec.gov/Archives/edgar/data/1737287/000138713120005873/0001387131-20-005873-index.htm |
| 2020-06-19 | TPG Group Holdings (SBS) Advisors, Inc. | 10% Share Holder | Sell | 47,767.00 | 42.04 | 2,008,306.19 | 20,193,735.00 | https://www.sec.gov/Archives/edgar/data/1737287/000138713120005873/0001387131-20-005873-index.htm |
| 2020-06-18 | TPG Group Holdings (SBS) Advisors, Inc. | 10% Share Holder | Sell | 94,600.00 | 42.14 | 3,986,595.36 | 20,241,502.00 | https://www.sec.gov/Archives/edgar/data/1737287/000138713120005873/0001387131-20-005873-index.htm |
| 2020-06-17 | TPG Group Holdings (SBS) Advisors, Inc. | 10% Share Holder | Sell | 87,319.00 | 42.18 | 3,683,482.16 | 20,336,102.00 | https://www.sec.gov/Archives/edgar/data/1737287/000138713120005745/0001387131-20-005745-index.htm |
| 2020-06-16 | TPG Group Holdings (SBS) Advisors, Inc. | 10% Share Holder | Sell | 174,511.00 | 42.20 | 7,364,678.32 | 20,423,421.00 | https://www.sec.gov/Archives/edgar/data/1737287/000138713120005745/0001387131-20-005745-index.htm |
| 2020-06-15 | TPG Group Holdings (SBS) Advisors, Inc. | 10% Share Holder | Sell | 129,154.00 | 42.14 | 5,442,885.36 | 20,597,932.00 | https://www.sec.gov/Archives/edgar/data/1737287/000138713120005745/0001387131-20-005745-index.htm |
| 2020-06-04 | TPG Group Holdings (SBS) Advisors, Inc. | 10% Share Holder | Sell | 1,818.00 | 47.11 | 85,638.16 | 20,727,086.00 | https://www.sec.gov/Archives/edgar/data/1737287/000138713120005509/0001387131-20-005509-index.htm |
| 2020-06-03 | TPG Group Holdings (SBS) Advisors, Inc. | 10% Share Holder | Sell | 274,080.00 | 47.13 | 12,916,814.83 | 20,728,904.00 | https://www.sec.gov/Archives/edgar/data/1737287/000138713120005509/0001387131-20-005509-index.htm |
| 2020-06-03 | TPG Group Holdings (SBS) Advisors, Inc. | 10% Share Holder | Sell | 213,322.00 | 47.75 | 10,185,698.86 | 21,002,984.00 | https://www.sec.gov/Archives/edgar/data/1737287/000138713120005509/0001387131-20-005509-index.htm |
| 2019-05-14 | TPG Group Holdings (SBS) Advisors, Inc. | 10% Share Holder | Sell | 1,918,755.00 | 29.38 | 56,373,021.90 | 21,216,306.00 | https://www.sec.gov/Archives/edgar/data/1737287/000114036119009199/0001140361-19-009199-index.htm |
| 2019-03-13 | David D Chang | President and CEO | Buy | 173,000.00 | 2,168,625.00 | https://www.sec.gov/Archives/edgar/data/1737287/000120919119019755/0001209191-19-019755-index.htm | ||
| 2018-10-15 | PFIZER INC | 10% Share Holder | Buy | 55,556.00 | 18.00 | 1,000,008.00 | 22,032,040.00 | https://www.sec.gov/Archives/edgar/data/1737287/000007800318000080/0000078003-18-000080-index.htm |
| 2020-03-16 | David D Chang | President and CEO | Sell | 1,625.00 | 20.06 | 32,603.03 | 2,214,914.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465920002734/0001214659-20-002734-index.htm |
| 2020-03-16 | David D Chang | President and CEO | Sell | 18,710.00 | 19.24 | 360,012.21 | 2,215,426.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465920002734/0001214659-20-002734-index.htm |
| 2018-10-15 | TPG Group Holdings (SBS) Advisors, Inc. | 10% Share Holder | Buy | 675,000.00 | 18.00 | 12,150,000.00 | 23,135,061.00 | https://www.sec.gov/Archives/edgar/data/1737287/000090342318000561/0000903423-18-000561-index.htm |
| 2020-06-05 | OWEN N. WITTE | Director | Buy | 9,969.00 | 246,151.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465920005496/0001214659-20-005496-index.htm | ||
| 2018-10-15 | Franz B Humer | Director | Buy | 30,000.00 | 18.00 | 540,000.00 | 30,000.00 | https://www.sec.gov/Archives/edgar/data/1737287/000120919118055385/0001209191-18-055385-index.htm |
| 2018-10-15 | Arie Belldegrun | Director | Buy | 35,000.00 | 18.00 | 630,000.00 | 35,000.00 | https://www.sec.gov/Archives/edgar/data/1737287/000120919118055372/0001209191-18-055372-index.htm |
| 2020-08-03 | Veer Bhavnagri | General Counsel | Sell | 16,450.00 | 37.29 | 613,397.47 | 353,902.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465920006805/0001214659-20-006805-index.htm |
| 2020-09-01 | Veer Bhavnagri | General Counsel | Sell | 400.00 | 35.89 | 14,356.00 | 353,902.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465920007671/0001214659-20-007671-index.htm |
| 2020-10-01 | Veer Bhavnagri | General Counsel | Sell | 800.00 | 37.73 | 30,180.00 | 353,902.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465920008378/0001214659-20-008378-index.htm |
| 2020-10-06 | Veer Bhavnagri | General Counsel | Sell | 10,000.00 | 40.00 | 400,000.00 | 353,902.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465920008504/0001214659-20-008504-index.htm |
| 2020-09-01 | Veer Bhavnagri | General Counsel | Sell | 24,600.00 | 35.35 | 869,610.00 | 354,302.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465920007671/0001214659-20-007671-index.htm |
| 2020-10-01 | Veer Bhavnagri | General Counsel | Sell | 7,985.00 | 37.03 | 295,663.79 | 354,702.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465920008378/0001214659-20-008378-index.htm |
| 2020-10-01 | Veer Bhavnagri | General Counsel | Sell | 16,215.00 | 36.21 | 587,068.94 | 362,687.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465920008378/0001214659-20-008378-index.htm |
| 2020-10-06 | Veer Bhavnagri | General Counsel | Buy | 10,000.00 | 2.27 | 22,700.00 | 363,902.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465920008504/0001214659-20-008504-index.htm |
| 2020-08-03 | Veer Bhavnagri | General Counsel | Sell | 15,103.00 | 36.46 | 550,723.34 | 370,352.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465920006805/0001214659-20-006805-index.htm |
| 2019-03-13 | ALISON MOORE | Chief Technical Officer | Buy | 37,050.00 | 37,050.00 | https://www.sec.gov/Archives/edgar/data/1737287/000120919119019767/0001209191-19-019767-index.htm | ||
| 2019-06-03 | ALISON MOORE | Chief Technical Officer | Sell | 1,623.00 | 27.31 | 44,319.10 | 37,557.00 | https://www.sec.gov/Archives/edgar/data/1737287/000120919119034861/0001209191-19-034861-index.htm |
| 2020-09-01 | Veer Bhavnagri | General Counsel | Buy | 25,000.00 | 2.27 | 56,750.00 | 378,902.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465920007671/0001214659-20-007671-index.htm |
| 2020-10-01 | Veer Bhavnagri | General Counsel | Buy | 25,000.00 | 2.27 | 56,750.00 | 378,902.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465920008378/0001214659-20-008378-index.htm |
| 2020-08-03 | Veer Bhavnagri | General Counsel | Buy | 25,000.00 | 2.27 | 56,750.00 | 385,455.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465920006805/0001214659-20-006805-index.htm |
| 2019-06-03 | ALISON MOORE | Chief Technical Officer | Sell | 47,205.00 | 26.74 | 1,262,455.24 | 39,180.00 | https://www.sec.gov/Archives/edgar/data/1737287/000120919119034861/0001209191-19-034861-index.htm |
| 2020-06-04 | Arie Belldegrun | Director | Buy | 40,000.00 | 47.00 | 1,880,000.00 | 40,000.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465920005383/0001214659-20-005383-index.htm |
| 2020-03-16 | ERIC THOMAS SCHMIDT | Chief Financial Officer | Sell | 5,150.00 | 19.70 | 101,432.86 | 47,257.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465920002735/0001214659-20-002735-index.htm |
| 2020-03-16 | ERIC THOMAS SCHMIDT | Chief Financial Officer | Sell | 300.00 | 20.25 | 6,075.00 | 47,906.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465920002735/0001214659-20-002735-index.htm |
| 2019-03-13 | ERIC THOMAS SCHMIDT | Chief Financial Officer | Buy | 49,400.00 | 49,400.00 | https://www.sec.gov/Archives/edgar/data/1737287/000120919119019762/0001209191-19-019762-index.htm | ||
| 2020-03-16 | ALISON MOORE | Chief Technical Officer | Sell | 3,750.00 | 19.19 | 71,980.13 | 63,021.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465920002736/0001214659-20-002736-index.htm |
| 2019-06-28 | ALISON MOORE | Chief Technical Officer | Buy | 27,816.00 | 2.27 | 63,142.32 | 65,373.00 | https://www.sec.gov/Archives/edgar/data/1737287/000120919119039728/0001209191-19-039728-index.htm |
| 2019-07-26 | ALISON MOORE | Chief Technical Officer | Sell | 13,193.00 | 29.18 | 384,994.17 | 65,373.00 | https://www.sec.gov/Archives/edgar/data/1737287/000120919119043755/0001209191-19-043755-index.htm |
| 2019-07-29 | ALISON MOORE | Chief Technical Officer | Sell | 23,815.00 | 29.39 | 699,870.46 | 65,373.00 | https://www.sec.gov/Archives/edgar/data/1737287/000120919119043755/0001209191-19-043755-index.htm |
| 2019-07-30 | ALISON MOORE | Chief Technical Officer | Sell | 11,819.00 | 29.85 | 352,738.06 | 65,373.00 | https://www.sec.gov/Archives/edgar/data/1737287/000120919119043755/0001209191-19-043755-index.htm |
| 2019-09-16 | ALISON MOORE | Chief Technical Officer | Sell | 5,257.00 | 32.00 | 168,233.99 | 66,067.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465919005941/0001214659-19-005941-index.htm |
| 2019-09-17 | ALISON MOORE | Chief Technical Officer | Sell | 22,503.00 | 32.11 | 722,560.08 | 66,067.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465919005941/0001214659-19-005941-index.htm |
| 2019-09-18 | ALISON MOORE | Chief Technical Officer | Sell | 21,067.00 | 32.13 | 676,872.18 | 66,067.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465919005941/0001214659-19-005941-index.htm |
| 2019-09-16 | ALISON MOORE | Chief Technical Officer | Buy | 5,257.00 | 2.27 | 11,933.39 | 71,324.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465919005941/0001214659-19-005941-index.htm |
| 2019-07-30 | ALISON MOORE | Chief Technical Officer | Buy | 11,819.00 | 2.27 | 26,829.13 | 77,192.00 | https://www.sec.gov/Archives/edgar/data/1737287/000120919119043755/0001209191-19-043755-index.htm |
| 2019-07-26 | ALISON MOORE | Chief Technical Officer | Buy | 13,193.00 | 2.27 | 29,948.11 | 78,566.00 | https://www.sec.gov/Archives/edgar/data/1737287/000120919119043755/0001209191-19-043755-index.htm |
| 2020-03-18 | ERIC THOMAS SCHMIDT | Chief Financial Officer | Buy | 30,800.00 | 78,706.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465920002803/0001214659-20-002803-index.htm | ||
| 2019-06-03 | ALISON MOORE | Chief Technical Officer | Buy | 48,828.00 | 2.27 | 110,839.56 | 86,385.00 | https://www.sec.gov/Archives/edgar/data/1737287/000120919119034861/0001209191-19-034861-index.htm |
| 2019-09-18 | ALISON MOORE | Chief Technical Officer | Buy | 21,067.00 | 2.27 | 47,822.09 | 87,134.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465919005941/0001214659-19-005941-index.htm |
| 2019-09-17 | ALISON MOORE | Chief Technical Officer | Buy | 22,503.00 | 2.27 | 51,081.81 | 88,570.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465919005941/0001214659-19-005941-index.htm |
| 2019-07-29 | ALISON MOORE | Chief Technical Officer | Buy | 23,815.00 | 2.27 | 54,060.05 | 89,188.00 | https://www.sec.gov/Archives/edgar/data/1737287/000120919119043755/0001209191-19-043755-index.htm |
| 2020-03-18 | ALISON MOORE | Chief Technical Officer | Buy | 30,800.00 | 93,821.00 | https://www.sec.gov/Archives/edgar/data/1737287/000121465920002805/0001214659-20-002805-index.htm |